In this issue of Blood, Fink et al report that a single amino acid change in cereblon (CRBN), the direct target of thalidomide and its derivatives, confers sensitivity to immunomodulatory… Click to show full abstract
In this issue of Blood, Fink et al report that a single amino acid change in cereblon (CRBN), the direct target of thalidomide and its derivatives, confers sensitivity to immunomodulatory drugs in mice.1
               
Click one of the above tabs to view related content.